Tezepelumab as an Add-on Maintenance Treatment for Severe Asthma: Recommendations and Clinical/Economic Impact.

By HEOR Staff Writer

April 25, 2023

Tezepelumab as an add-on maintenance treatment is recommended as an option for severe asthma in people 12 years and over, when treatment with high-dose inhaled corticosteroids plus another maintenance treatment has failed.

It is recommended only if people:

  • Have had 3 or more exacerbations in the previous year, or
  • Are having maintenance oral corticosteroids.

Tezepelumab should be discontinued if the rate of severe asthma exacerbations, or the maintenance oral corticosteroid dose, have not been reduced by at least 50% at 12 months.

Clinical impact:
Clinical trial results show that tezepelumab, when added to usual treatment, reduces exacerbations and the dose of oral corticosteroids needed, compared with placebo. An indirect comparison of tezepelumab with other biological treatments suggests similar clinical effectiveness, but this is uncertain.

Economic impact:
The cost-effectiveness estimates show that Tezepelumab as an add-on maintenance therapy is cost effective compared with standard care and other biological (benralizumab, mepolizumab, reslizumab, dupilumab and omalizumab) treatments.

Reference url

Recent Posts

Tukysa Breast Cancer Therapy Boosts Progression-Free Survival in Advanced Cases

By João L. Carapinha

October 15, 2025

Tukysa breast cancer therapy, developed by Pfizer, has shown remarkable efficacy in improving progression-free survival (PFS) for patients with HER2-positive metastatic breast cancer. Recent findings indicate that the combination of Tukysa (tucatinib) with trastuzumab and capecitabine significant...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Triple-Negative Breast Ca...

By João L. Carapinha

October 13, 2025

Datroway TNBC therapy (datopotamab deruxtecan) has demonstrated statistically significant and clinically meaningful improvements in overall survival (OS) and progression-free survival (PFS) as a first-line treatment compared to chemotherapy in patients with metastatic triple-negative breast cance...
Evolving Burden of Obesity in the US: Key Insights on Obesity Prevention Strategies

By HEOR Staff Writer

October 10, 2025

What are the most effective obesity prevention strategies for reducing long-term healthcare and societal costs in the United States? Recent advanced population models reveal that focusing on early, targeted obesity prevention strategies offers far greater value to health systems and society than ...